Intervention

Semaglutide (Wegovy®)

ClinicalTrials.gov intervention label

Clinical trials2

Recruiting0

Common conditions3

Lead sponsors shown2

Clinical trials

2 shown

Brown Adipose Tissue as a Mechanistic Determinant of Semaglutide Treatment Response in Obesity (BAT-Sema Study)NCT07621640 · 2026-06-01

NOT_YET_RECRUITING

Sequential Therapy Anti-obesitY Medication With Muscle Preservation for Weight Loss and MaintEnance: A PragmAtic Randomized CoNtrolled Trial (STAY-LEAN Trial)NCT06854614 · 2025-03-01

ACTIVE_NOT_RECRUITING

Common conditions

Obesity2 Brown Adipose Tissue1 Metabolic Syndrome1

Leading sponsors

Hallym University1 The Cleveland Clinic1

Trial status mix

ACTIVE_NOT_RECRUITING1

NOT_YET_RECRUITING1

Phase mix

NA1

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.